Early differences in dynamic uptake of 68Ga-PSMA-11 in primary prostate cancer: A test-retest study.
IntroductionDynamic PET/CT allows visualization of pharmacokinetics over the time, in contrast to static whole body PET/CT.The objective of this study was to assess 68Ga-PSMA-11 uptake in pathological lesions and benign tissue, within 30 minutes after injection in primary prostate cancer (PCa) patients in test-retest setting.Materials and methodsFi